What's Happening?
A new report by Deloitte Center for Health Solutions reveals significant shifts in the diagnostics manufacturing sector towards a business-to-business-to-consumer (B2B2C) model. The report indicates that
62% of diagnostics manufacturer executives see future growth dependent on this model, driven by rising consumer demand for self-ordered testing and digital health tools. The study highlights a disconnect between manufacturers and healthcare providers, with providers identifying test ordering as a major friction point, while manufacturers focus on results interpretation. The report emphasizes the need for manufacturers to integrate AI and improve interoperability to meet consumer expectations and support healthcare providers in a rapidly evolving market.
Why It's Important?
The shift towards a consumer-driven diagnostics model reflects broader trends in healthcare towards personalization and patient empowerment. As consumers increasingly use digital health tools, traditional healthcare providers face pressure to adapt or risk losing market share to tech-savvy entrants. The report underscores the importance of interoperability and AI integration in creating seamless, personalized healthcare experiences. This transition presents opportunities for diagnostics manufacturers to innovate and align more closely with provider needs, potentially reshaping the competitive landscape. The findings highlight the critical role of technology in enabling this transformation and the need for strategic alignment across the healthcare ecosystem.
What's Next?
Diagnostics manufacturers are expected to focus on enhancing AI capabilities and improving data integration to support personalized healthcare delivery. The report suggests that manufacturers need to re-engineer their interactions with healthcare providers, focusing on reducing test ordering friction and engaging with clinical stakeholders. As consumer-initiated testing becomes more prevalent, manufacturers will need to adapt their business models to support decentralized care networks. The ongoing evolution of the diagnostics market will likely drive further innovation and collaboration between manufacturers and healthcare providers, with a focus on delivering value-driven, consumer-centric solutions.
